SVETLANA PYATIGORSKAYA: Open Payments
NPI 1063509081 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,347 in 58 payments from 13 companies in 2025. Trend: 2023 $578 · 2024 $993 · 2025 $1,347
Food & beverage: $1,247Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $377 |
| Amgen Inc. | 8 | $158 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $152 |
| PFIZER INC. | 7 | $147 |
| Ardelyx, Inc. | 4 | $138 |
| Astellas Pharma US Inc | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 3 | $81 |
| SHIELD THERAPEUTICS INC | 1 | $25 |
| SCILEX PHARMACEUTICALS INC. | 1 | $22 |
Products named: UBRELVY, XIFAXAN, IBSRELA, NURTEC ODT, LINZESS, OTEZLA, LEQVIO, QULIPTA.
Industry payments across NY — which companies pay providers there.
